STIM

#3296
Neuronetics, Inc. Common Stock
1.34
0.00%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
1.34
1.34
Yıllık aralık
1.20
5.92
Günlük değişim
0.00%
Aylık değişim
-39.64%
6 aylık değişim
-60.59%
Yıllık değişim
-68.98%
Önceki kapanış
1.34
Open
1.34
Bid
Ask
Low
1.34
High
1.34
Hacim
27
Open full chart

Financials

Overview Rapor Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value 20202021202220232024 TTM

Neuronetics Inc

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device." They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head.

Haberler